Sunday 18 October 2026 Export IGC’s income statement to Excel — free account

IGC Pharma, Inc.

IGC Pharma, Inc.’s revenue for fiscal 2025 (year ended March 2025) was $1.3 million, down 5.50% from fiscal 2024. In the quarter to June 2026, revenue fell 19.7%, EPS fell 100.0%, free cash flow fell 103.3% and total debt rose 713.5%, each against the same quarter a year earlier. Operating cash flow growth for five consecutive years.

0.25 0.00 0.00%

Follow IGC

Alert me

Market cap: $26.3M
P/E: 0.0×
Fwd P/E: −3.6×
Dividend yield: —
F-score: 3/9
Altman Z: −16.58
Beneish M: −3.69
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
Piotroski F-Score Full definition →	+8 more TTM periods Free account	3	—	1	1
ROE Full definition →		(83.35%)	0.00%	(112.76%)	(143.46%)
ROA Full definition →		(64.11%)	0.00%	(78.30%)	(100.44%)
ROIC Full definition →		(52.51%)	0.00%	(79.70%)	(91.53%)
Return on Tangible Assets Full definition →		(241.91%)	0.00%	(1,862.07%)	(7,422.03%)
Average Days of Receivables Full definition →		13.53	0.00	11.58	18.56
Free Cash Flow per Share Full definition →		(0.05)	—	(0.04)	(0.06)
Free Cash Flow Full definition →		(4.83)	—	(4.08)	(5.69)
Capital Expenditures Full definition →		(0.02)	—	0.64	(0.35)
Other line items
Cash ROIC Full definition →		(51.69%)	0.00%	(56.08%)	(75.15%)
Accounts Receivable Turnover Full definition →		26.02	0.00	32.85	15.40
Accounts Payable Turnover Full definition →		0.85	0.00	0.66	0.58
Inventory Turnover Full definition →		0.55	0.00	0.70	0.75
Average Days of Payables Full definition →		385.24	0.00	650.67	792.71
Days of Inventory on Hand Full definition →		403.65	0.00	330.78	313.56
Tax Rate Full definition →		0.00	—	0.00	0.00
Research and Development Expense of Revenue Full definition →		387.70%	—	403.77%	463.31%
Selling, General and Administrative Expense of Revenue Full definition →		390.42%	—	379.85%	481.47%
Share Based Compensation of Revenue Full definition →		141.32%	—	187.91%	225.52%
Operating CF/Net income Full definition →		0.75	—	0.67	0.61
Depreciation/Fixed assets Full definition →		0.19	0.00	0.15	0.11
Capex/Depreciation Full definition →		(0.05)	—	2.02	(1.58)
Revenue per Share Full definition →		0.01	—	0.01	0.01
Operating CF per Share Full definition →		(0.05)	—	(0.05)	(0.05)
Capex per Share Full definition →		0.00	—	0.01	0.00
Capex to Sales Full definition →		0.02	—	(0.55)	0.32

Show all line items

Columns are period end dates · fundamentals updated 5 Oct 2026

Stockrow Weekly